Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Rotational Atherectomy System Treats In-Stent Restenosis

By HospiMedica International staff writers
Posted on 19 Oct 2021
A rotational excisional device removes and aspirates varying lesion morphologies, including within peripheral arteries fitted with stents, stent grafts, and native or artificial bypasses.

The BD (Franklin Lakes, NJ, USA) Rotarex Atherectomy System is a precision device that negotiates even complex lesions without using external blades. More...
Its core component is a rotating atraumatic catheter head with blunt facets that is connected to a rotating helix; both catheter head and helix rotate at approximately 40,000-60,000 rpm. Additional luminal gain is achieved by a vortex created around the rotating cylinder, side windows that remove detached material, and continuous negative pressure created at the tip by the rotating helix, to aspirate and transport debris away.

The small footprint system requires no warm-up, infusion, or repeated catheter cleaning, with a magnetically coupled hand or foot switch that facilitates use in the sterile environment. Additional system components include an auto-aspirating drive pump; a polytetrafluoroethylene (PTFE) coated nitinol core shaft with a flexible, angled tip to enable lesion crossing; a gold-plated tungsten coil to enhance visualization under fluoroscopy; and a high volume collecting bag that allows the system to be used continuously.

“The additional indications provide physicians a one-of-a-kind, ideal solution for treating complex lesions associated with peripheral arterial disease and further demonstrates our responsibility as an industry to develop innovative technologies to help with the fight against peripheral artery disease,” said Paddy O'Brien, worldwide president of Peripheral Intervention for BD, commenting on the new, expanded in-stent restenosis indications issued by the U.S. Food and Drug Administration (FDA).

“The Rotarex Atherectomy System is quick and efficient for treating arterial lesions,” said Prakash Krishnan, MD, of Mount Sinai Health System (New York, NY, USA). “With ability to use it for both atherectomy and thrombectomy, it is now a great product to be able to treat in-stent restenosis. Rotarex has been a great device for me to have in my practice, and I am excited about these new indications.”

Peripheral artery disease (PAD) results when the peripheral arteries become narrow or obstructed due to plaque, limiting blood flow to the legs. If left untreated, it can cause pain or aching in the legs, difficulty with walking, resting pain in the foot at night in bed, non-healing sores or infections in the toes or feet, and can ultimately lead to limb loss in its most severe form. In addition, it can be associated with other serious arterial conditions that can lead to heart attacks and stroke.

Related Links:
BD
Mount Sinai Health System



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
PACS Workstation
PaxeraView PRO
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.